Patents by Inventor Steven Richard Witowski

Steven Richard Witowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salts of an epidermal growth factor receptor kinase inhibitor
    Patent number: 11292772
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: April 5, 2022
    Assignee: Celgene CAR LLC
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
    Publication number: 20210017137
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: February 21, 2020
    Publication date: January 21, 2021
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • Salts of an epidermal growth factor receptor kinase inhibitor
    Patent number: 10570099
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 25, 2020
    Assignee: Celgene CAR LLC
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
    Publication number: 20190152925
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: June 22, 2018
    Publication date: May 23, 2019
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • Salts of an epidermal growth factor receptor kinase inhibitor
    Patent number: 10005738
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: June 26, 2018
    Assignee: Celgene CAR LLC
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
    Publication number: 20170217904
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: January 9, 2017
    Publication date: August 3, 2017
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • Besylate salt of a BTK inhibitor
    Patent number: 9604936
    Abstract: The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: March 28, 2017
    Assignee: Celgene CAR LLC
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Richland Wayne Tester
  • Salts of an epidermal growth factor receptor kinase inhibitor
    Patent number: 9540335
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: January 10, 2017
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER
    Publication number: 20160287588
    Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with BTK.
    Type: Application
    Filed: June 9, 2016
    Publication date: October 6, 2016
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Heather Lounsbury, Kathryn Stiede, Bruce A. Silver, Jay M. Mei
  • Methods of treating a Bruton's Tyrosine Kinase disease or disorder
    Patent number: 9364476
    Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with BTK.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: June 14, 2016
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Heather Lounsbury, Kathryn Stiede, Bruce A. Silver, Jay M. Mei
  • SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
    Publication number: 20150344441
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: August 10, 2015
    Publication date: December 3, 2015
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • Salts of an epidermal growth factor receptor kinase inhibitor
    Patent number: 9108927
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: August 18, 2015
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • BESYLATE SALT OF A BTK INHIBITOR
    Publication number: 20140057929
    Abstract: The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 27, 2014
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Richland Wayne Tester
  • Besylate salt of a BTK inhibitor
    Patent number: 8563568
    Abstract: The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: October 22, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Richland Wayne Tester
  • SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
    Publication number: 20130267531
    Abstract: The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Mei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
  • BESYLATE SALT OF A BTK INHIBITOR
    Publication number: 20120077832
    Abstract: The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: August 8, 2011
    Publication date: March 29, 2012
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Richland Wayne Tester